Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis
Amanda J. Walne,
Laura Collopy,
Shirleny Cardoso,
Alicia Ellison,
Vincent Plagnol,
Canan Albayrak,
Davut Albayrak,
Sara Sebnem Kilic,
Turkan Patıroglu,
Haluk Akar,
Keith Godfrey,
Tina Carter,
Makia Marafie,
Ajay Vora,
Mikael Sundin,
Thomas Vulliamy,
Hemanth Tummala,
Inderjeet Dokal
Affiliations
Amanda J. Walne
Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Barts NHS Trust, London, UK
Laura Collopy
Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Barts NHS Trust, London, UK
Shirleny Cardoso
Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Barts NHS Trust, London, UK
Alicia Ellison
Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Barts NHS Trust, London, UK
Vincent Plagnol
University College London Genetics Institute, UK
Canan Albayrak
Department of Pediatric Hematology, Ondokuz Mayis University, Samsun, Turkey
Davut Albayrak
Department of Pediatric Hematology, Ondokuz Mayis University, Samsun, Turkey
Sara Sebnem Kilic
Department of Pediatric Immunology Uludag University, Bursa, Turkey
Turkan Patıroglu
Department of Pediatric Immunology Erciyes University Medical Facility, Kayseri, Turkey
Haluk Akar
Department of Pediatric Immunology Erciyes University Medical Facility, Kayseri, Turkey
Keith Godfrey
Department of Pediatric Dermatology and NIHR Southampton Biomedical Research Center, University Hospital, Southampton and University of Southampton, UK
Tina Carter
Department of Oncology and Haematology, Princess Margaret Hospital, Perth, WA, Australia
Makia Marafie
Clinical Cancer and Community Genetics, Kuwait Medical Genetics Center, Al-Sabah Medical area, Kuwait
Ajay Vora
Department of Haematology, Sheffield Children’s NHS foundation Trust, Sheffield, UK
Mikael Sundin
Section of Pediatric Hematology/Immunology/SCT, Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden;Division of Pediatrics, CLINTEC, Karolinska Institutet, Stockholm, Sweden
Thomas Vulliamy
Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Barts NHS Trust, London, UK
Hemanth Tummala
Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Barts NHS Trust, London, UK
Inderjeet Dokal
Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Barts NHS Trust, London, UK
Dyskeratosis congenita is a highly pleotropic genetic disorder. This heterogeneity can lead to difficulties in making an accurate diagnosis and delays in appropriate management. The aim of this study was to determine the underlying genetic basis in patients presenting with features of dyskeratosis congenita and who were negative for mutations in the classical dyskeratosis congenita genes. By whole exome and targeted sequencing, we identified biallelic variants in genes that are not associated with dyskeratosis congenita in 17 individuals from 12 families. Specifically, these were homozygous variants in USB1 (8 families), homozygous missense variants in GRHL2 (2 families) and identical compound heterozygous variants in LIG4 (2 families). All patients had multiple somatic features of dyskeratosis congenita but not the characteristic short telomeres. Our case series shows that biallelic variants in USB1, LIG4 and GRHL2, the genes mutated in poikiloderma with neutropenia, LIG4/Dubowitz syndrome and the recently recognized ectodermal dysplasia/short stature syndrome, respectively, cause features that overlap with dyskeratosis congenita. Strikingly, these genes also overlap in their biological function with the known dyskeratosis congenita genes that are implicated in telomere maintenance and DNA repair pathways. Collectively, these observations demonstrate the marked overlap of dyskeratosis congenita with four other genetic syndromes, confounding accurate diagnosis and subsequent management. This has important implications for establishing a genetic diagnosis when a new patient presents in the clinic. Patients with clinical features of dyskeratosis congenita need to have genetic analysis of USB1, LIG4 and GRHL2 in addition to the classical dyskeratosis congenita genes and telomere length measurements.